Ask Us a Question

[Sonata Peptides]

Retatrutide 40mg per Vial would be fabulous ngl !

Thank you for your opinion, we will take it into account.

 

[Sonata Peptides]

we need tesofensine

We mainly specialize in injectable peptide products.

 

[Sonata Peptides]

Pushing 40mg over 4 weeks in BAC with its slightly acidic nature will hold it together, but it will degrade. But you have to factor the degradation, how much are you using (10mg death champ) or 5mg is your max dose.

I would enjoy multiple dose options, I know it will come. Do I think 40mg is a lot to store in a vial, make room for much more than 1ml of BAC.

It all depends on the dosing, because some people use 10 mg or even more, meaning the storage period would only be around 3–4 weeks.

Our kits include 2 ml vial of bacteriostatic water.

 

[Sonata Peptides]

Pushing 40mg over 4 weeks in BAC with its slightly acidic nature will hold it together, but it will degrade. But you have to factor the degradation, how much are you using (10mg death champ) or 5mg is your max dose.

I would enjoy multiple dose options, I know it will come. Do I think 40mg is a lot to store in a vial, make room for much more than 1ml of BAC.

It all depends on the dosing, because some people use 10 mg or even more, meaning the storage period would only be around 3–4 weeks.

Our kits include 2 ml vial of bacteriostatic water.

 

[Filko87]

We’ll be happy to answer any of your questions.​

hey guys, when will reta come back to stock?

 

[Sonata Peptides]

hey guys, when will reta come back to stock?

At the moment, peptides like Reta will be available in stores after the initial part of the lineup we announced first is released.

 

[xccdf]

It all depends on the dosing, because some people use 10 mg or even more, meaning the storage period would only be around 3–4 weeks.

Our kits include 2 ml vial of bacteriostatic water.

But they have to titrate up to that dose. Reta is very strong, and the unfolding and stickiness to the glass has to be factored in.

Me, I am a hyper responder. At 8mg I am not eating. What I ate on Monday is still in my stomach Wednesday.

That being said I would 100% purchase it from here. Ive had it tested, its within super pharma grade ranges (+-1%) which is unheard of.

But smaller batches and larger batches would be welcomed.

I can't buy a 40mg vial. I can buy a 20mg and run through it before it degrades.

 

[Mr.Btc98]

I’m considering a very cautious retatrutide protocol because I have a history of panic attacks and anxiety. The idea would be to start extremely low at 0.5 mg once weekly, stay there for 5 weeks, then increase to 1 mg for another 5 weeks, and only then move to 2 mg and hold that dose for a while.

My main concerns are safety, side effects, and what happens when stopping the medication. Would starting this low meaningfully reduce the risk of side effects, or are there still risks even at these micro-doses? Also, is there any recommended way to discontinue retatrutide to avoid rebound effects or other issues? I’d appreciate a medically grounded opinion, especially considering my anxiety and panic disorder history.

 

[bezuMM]

Hey, any news?

 

[Sonata Peptides]

But they have to titrate up to that dose. Reta is very strong, and the unfolding and stickiness to the glass has to be factored in.

Me, I am a hyper responder. At 8mg I am not eating. What I ate on Monday is still in my stomach Wednesday.

That being said I would 100% purchase it from here. Ive had it tested, its within super pharma grade ranges (+-1%) which is unheard of.

But smaller batches and larger batches would be welcomed.

I can't buy a 40mg vial. I can buy a 20mg and run through it before it degrades.

From our experience, not everyone keeps increasing the dosage indefinitely. If a person has a very large amount of excess weight, then yes — in those cases the dose often has to be increased over time.

But very often what happens is that someone loses 10–15 kg of excess weight and then switches to maintenance dosing, which is usually lower than the doses used for active appetite suppression.

Thank you for your feedback. It’s becoming increasingly clear to us that having a wider variety of dosage formats available is simply better for everyone.

 

[Sonata Peptides]

I’m considering a very cautious retatrutide protocol because I have a history of panic attacks and anxiety. The idea would be to start extremely low at 0.5 mg once weekly, stay there for 5 weeks, then increase to 1 mg for another 5 weeks, and only then move to 2 mg and hold that dose for a while.

My main concerns are safety, side effects, and what happens when stopping the medication. Would starting this low meaningfully reduce the risk of side effects, or are there still risks even at these micro-doses? Also, is there any recommended way to discontinue retatrutide to avoid rebound effects or other issues? I’d appreciate a medically grounded opinion, especially considering my anxiety and panic disorder history.

Since days no reply. Seems to be nooby lvl of support. Poor quality.

First of all, I apologize for the delay in replying. Our project on the forum has not fully launched yet, and right now we have a huge amount of preparatory work, including work related to products. I will try to respond faster.

​

Regarding panic attacks​

Considering your history of panic attacks and anxiety disorder, your approach seems very reasonable and much safer to me than standard rapid titration. What you described is essentially “psychiatric-sensitive titration,” and for a person with anxiety vulnerability this looks logical. Because of the glucagon component, some people experience: increased heart rate, a feeling of internal “activation,” stimulation, strange bodily sensations (warmth, tingling, dysesthesia). For someone with panic disorder, bodily sensations themselves are often the trigger.

Slow titration usually dramatically improves tolerability. Most GI and CNS side effects of GLP-1 drugs depend on:
the speed of dose escalation, peak concentrations, and how quickly the brain/GI tract adapt. Virtually all clinical experience with semaglutide/tirzepatide shows: slower titration = less nausea/anxiety/dropout. And in Retatrutide studies, side effects were dose-dependent.

Anxiety disorder is not a contraindication, but it is a reason to proceed carefully. The data regarding psychiatric effects of GLP-1 drugs is still contradictory: some studies show increased anxiety/depression signals, while others show improved mood and reduced compulsive eating. But the more important point is this: if you already have panic sensitivity, then: tachycardia, nausea, hypoglycemia-like sensations can subjectively feel like the beginning of a panic attack. Therefore your strategy of “letting the nervous system adapt” is very sensible.

I would also think about several additional things:
Do not increase the dose based on the calendar, but based on stability of condition. If everything feels perfect at 1 mg — then you can increase. If there is even mild activation — better to stay there another 2–4 weeks.

During the first 24–48 hours after injection — monitor yourself especially carefully and avoid: strong calorie deficits, dehydration, excessive caffeine (although you probably already know this). This significantly reduces the risk of panic-like physiology.

Retatrutide and GLP-1 drugs in general can slightly increase heart rate. For anxious people this is psychologically important. Honestly, I would even say your protocol is closer to how these drugs probably should be titrated in sensitive people from the beginning.
Yes, for Retatrutide (like other GLP-1/GIP/glucagon agonists), it is currently generally recommended not to stop abruptly, but to taper gradually — although there is still no official standardized protocol. Retatrutide is still under investigation, so recommendations are mostly extrapolated from semaglutide/tirzepatide experience and early triple agonist data.

What is currently known:
After stopping GLP-1 drugs, people often experience: increased appetite, partial or significant weight regain, worsening glycemia/insulin resistance, return of “food noise.” Abrupt discontinuation (“cold turkey”) is associated with stronger rebound effects, therefore many specialists recommend tapering.

In practice, people usually use approaches such as gradual dose reduction. For example: 12 mg, then 8, then 4 mg,
or increasing the interval between injections: once every 7 days, then every 10–14 days, then once every 3 weeks and discontinuation.
Usually these steps are done every 2–6 weeks depending on: appetite, body weight, glucose, tolerability.

Maintenance phase before full discontinuation
Many people achieve the best results not by stopping immediately after weight loss, but after: 3–12 months of stable weight,
solidifying eating habits, resistance training, normalizing sleep and stress. Some people remain on minimal maintenance doses long-term. It is very important at this point to strongly emphasize protein intake and resistance training. This is critical after discontinuation:
high protein helps control appetite, resistance training reduces metabolic slowdown and muscle loss.

It is important to understand one thing: modern data increasingly suggests that obesity is a chronic condition, and for many people GLP-1 therapy functions more like long-term treatment rather than a temporary course. Therefore rebound after discontinuation is not “weak willpower,” but a biological response and a return toward the original baseline. That is why I would recommend viewing Retatrutide more like a “boost pedal” — you use it when you need to reduce weight and remove it once the goal is achieved, taper down gradually and either fully discontinue for some time or remain on a minimal maintenance dose.

If you remove it completely, then most likely your eating habits will gradually return (not immediately of course) and you will slowly begin gaining weight again. You simply need to determine in advance at what point you begin taking it again.

For example: suppose you weigh 100 kg and lose weight down to 80 kg. After that you taper down and take a break, while already planning a new cycle once your weight reaches 85 kg again. Maybe you reach 85 kg again after 2 months, or maybe after a year — depending on metabolism, diet, training, and so on.

 

[Sonata Peptides]

Hey, any news?

At the moment, our partners are actively progressing and are currently finalizing the necessary organizational and technical processes, including the setup of the payment infrastructure. Once the full launch is completed, they will provide all additional information, and the website will be published on the forum.

 

[Mr.Btc98]

First of all, I apologize for the delay in replying. Our project on the forum has not fully launched yet, and right now we have a huge amount of preparatory work, including work related to products. I will try to respond faster.

​

Regarding panic attacks​

Considering your history of panic attacks and anxiety disorder, your approach seems very reasonable and much safer to me than standard rapid titration. What you described is essentially “psychiatric-sensitive titration,” and for a person with anxiety vulnerability this looks logical. Because of the glucagon component, some people experience: increased heart rate, a feeling of internal “activation,” stimulation, strange bodily sensations (warmth, tingling, dysesthesia). For someone with panic disorder, bodily sensations themselves are often the trigger.

Slow titration usually dramatically improves tolerability. Most GI and CNS side effects of GLP-1 drugs depend on:
the speed of dose escalation, peak concentrations, and how quickly the brain/GI tract adapt. Virtually all clinical experience with semaglutide/tirzepatide shows: slower titration = less nausea/anxiety/dropout. And in Retatrutide studies, side effects were dose-dependent.

Anxiety disorder is not a contraindication, but it is a reason to proceed carefully. The data regarding psychiatric effects of GLP-1 drugs is still contradictory: some studies show increased anxiety/depression signals, while others show improved mood and reduced compulsive eating. But the more important point is this: if you already have panic sensitivity, then: tachycardia, nausea, hypoglycemia-like sensations can subjectively feel like the beginning of a panic attack. Therefore your strategy of “letting the nervous system adapt” is very sensible.

I would also think about several additional things:
Do not increase the dose based on the calendar, but based on stability of condition. If everything feels perfect at 1 mg — then you can increase. If there is even mild activation — better to stay there another 2–4 weeks.

During the first 24–48 hours after injection — monitor yourself especially carefully and avoid: strong calorie deficits, dehydration, excessive caffeine (although you probably already know this). This significantly reduces the risk of panic-like physiology.

Retatrutide and GLP-1 drugs in general can slightly increase heart rate. For anxious people this is psychologically important. Honestly, I would even say your protocol is closer to how these drugs probably should be titrated in sensitive people from the beginning.
Yes, for Retatrutide (like other GLP-1/GIP/glucagon agonists), it is currently generally recommended not to stop abruptly, but to taper gradually — although there is still no official standardized protocol. Retatrutide is still under investigation, so recommendations are mostly extrapolated from semaglutide/tirzepatide experience and early triple agonist data.

What is currently known:
After stopping GLP-1 drugs, people often experience: increased appetite, partial or significant weight regain, worsening glycemia/insulin resistance, return of “food noise.” Abrupt discontinuation (“cold turkey”) is associated with stronger rebound effects, therefore many specialists recommend tapering.

In practice, people usually use approaches such as gradual dose reduction. For example: 12 mg, then 8, then 4 mg,
or increasing the interval between injections: once every 7 days, then every 10–14 days, then once every 3 weeks and discontinuation.
Usually these steps are done every 2–6 weeks depending on: appetite, body weight, glucose, tolerability.

Maintenance phase before full discontinuation
Many people achieve the best results not by stopping immediately after weight loss, but after: 3–12 months of stable weight,
solidifying eating habits, resistance training, normalizing sleep and stress. Some people remain on minimal maintenance doses long-term. It is very important at this point to strongly emphasize protein intake and resistance training. This is critical after discontinuation:
high protein helps control appetite, resistance training reduces metabolic slowdown and muscle loss.

It is important to understand one thing: modern data increasingly suggests that obesity is a chronic condition, and for many people GLP-1 therapy functions more like long-term treatment rather than a temporary course. Therefore rebound after discontinuation is not “weak willpower,” but a biological response and a return toward the original baseline. That is why I would recommend viewing Retatrutide more like a “boost pedal” — you use it when you need to reduce weight and remove it once the goal is achieved, taper down gradually and either fully discontinue for some time or remain on a minimal maintenance dose.

If you remove it completely, then most likely your eating habits will gradually return (not immediately of course) and you will slowly begin gaining weight again. You simply need to determine in advance at what point you begin taking it again.

For example: suppose you weigh 100 kg and lose weight down to 80 kg. After that you taper down and take a break, while already planning a new cycle once your weight reaches 85 kg again. Maybe you reach 85 kg again after 2 months, or maybe after a year — depending on metabolism, diet, training, and so on.

Thank you for the detailed answer. I understand the logic behind slow titration, especially with panic disorder.

However, I want to clarify one important point: since retatrutide is still investigational and not officially approved, what quality-control documentation can you provide for the product itself, such as third-party HPLC/LC-MS testing, purity, sterility/endotoxin testing, batch-specific certificates, and confirmation of correct dosage?

Also, when you say tapering is generally recommended, is this based on retatrutide-specific clinical data, or is it extrapolated from semaglutide/tirzepatide experience?